Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Mainstream Perp DEX Overview: Only TradeXYZ trading volume has surpassed the rest of the platforms, accounting for approximately 38% of Hyperliquid's overall trading volume

Mainstream Perp DEX Overview: Only TradeXYZ trading volume has surpassed the rest of the platforms, accounting for approximately 38% of Hyperliquid's overall trading volume

BlockBeatsBlockBeats2026/04/07 11:01

BlockBeats News, April 7th, according to DefiLlama data, the HIP-3 ecosystem project TradeXYZ's trading volume continues to rise, reaching $24 billion in total trading volume, with the open interest also surpassing $22 billion, both overtaking other platforms, currently accounting for 38% of the overall Hyperliquid trading volume. The current main Perp DEX trading volume rankings are as follows:


Hyperliquid (including TradeXYZ): 24-hour trading volume is around $71.0 billion, with an open interest of around $76.3 billion;


-TradeXYZ: 24-hour trading volume is around $24.18 billion, with an open interest of around $22.33 billion;


EdgeX: 24-hour trading volume is around $22.15 billion, with an open interest of around $10.01 billion;


Lighter: 24-hour trading volume is around $18.8 billion, with an open interest of around $6.61 billion;


Aster: 24-hour trading volume is around $18.29 billion, with an open interest of around $18.03 billion;


Pacifica: 24-hour trading volume is around $4.31 billion, with an open interest of around $78.93 million;

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12